B.C. biotech firm gets U.S. authorization for COVID-19 antibody
A local biotech company has discovered another antibody that will soon be used to treat COVID-19 patients.
AbCellera, based in Vancouver, developed bebtelovimab, an antibody that prevents further spread of the coronavirus in someone who’s recently been infected.
The drug is being manufactured by Eli Lilly and Company, and was developed in collaboration with the biotech firm that started in 2012 out of a lab at UBC.
“We’re excited that a company that was founded and built right here in Vancouver, has now stepped up on the world stage to bring the next generation of solutions for COVID-19," said AbCellera CEO Carl Hansen.
Bebtelovimab works by sticking to the virus and preventing the virus’ ability to infect the cell and propagate within the body, Hansen explained.
He said the antibody therapy could be used shortly after being infected to prevent hospitalization and possible death.
“So that is something that can literally save lives, if delivered quickly,” he said.
On Feb. 11, the U.S. Food and Drug Administration granted emergency use authorization to treat mild-to-moderate COVID-19 patients 12 years old and older with bebtelovimab.
“Today’s action makes available another monoclonal antibody that shows activity against Omicron, at a time when we are seeking to further increase supply,” said Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, in a press release.
“This authorization is an important step in meeting the need for more tools to treat patients as new variants of the virus continue to emerge.”
Hansen said the new therapy has shown to be effective in treating Omicron and its subvariant BA.2.
Infectious disease expert Dr. Brian Conway said the first line of defence against hospitalizations and death is still through vaccination.
“This is not a replacement for vaccination, then we need to educate each other about the role of treatments in general terms. All of these treatments via the antiviral medications, the monoclonal antibodies, or other treatments that are being evaluated are meant to reduce the risk of hospitalization,” he said.
Hansen agrees that vaccines are still the primary tool in the fight against COVID-19.
“What we are bringing forward here is a complementary solution. So for whatever reason, there will be people that choose not to get vaccinated. There will also be people that because they are immune compromised, will not benefit from vaccines. Those people may well get ill and when they do, they need options,” he said.
This is the biotech company’s second antibody discovery.
In Nov. 2020, Health Canada approved bamlanivimab, which Hansen said has helped to treat 1.5 million people globally and has prevented an estimated 100,000 hospitalizations and 40,000 deaths.
Currently, Health Canada is reviewing eight COVID-19 treatments. It has already approved five treatment options.
Correction
This story has been updated to remove a reference to Health Canada reviewing bebtelovimab. AbCellera's partner Eli Lilly is responsible for submitting drugs to Health Canada for regulartory approval and so far has not done so for bebtelovimab.
CTVNews.ca Top Stories
![](https://www.ctvnews.ca/polopoly_fs/1.6954857.1720387155!/httpImage/image.jpg_gen/derivatives/landscape_800/image.jpg)
Alice Munro's daughter says mom kept silent when stepfather sexually abused her
The youngest daughter of celebrated Canadian author Alice Munro has opened up about sexual abuse by her stepfather and the deep hurt she felt when her mother chose to support her husband instead of her child.
France election: Left-wing coalition wins most seats, beating far-right party
A coalition of the French left that quickly banded together to beat a surging far right in legislative elections won the most seats in parliament but not a majority, according to polling projections Sunday, a stunning outcome that threatens to plunge the country into political and economic turmoil.
Bus crashes into electrical pylon, causing massive power outage on the South Shore
Tens of thousands of households on Montreal's South Shore have been without electricity since Saturday night after a bus crashed into an electrical pylon.
Ottawa councillor, residents condemn arrival of 'hateful' group Diagolon 'Terror Tour'
A community group and an Ottawa city councillor have come forward to condemn the arrival of the far-right group Diagolon after it brought its 'Road Rage Terror Tour' to Ottawa over the weekend.
Planning a last-minute summer vacation? Here's how to save money
Summer is already in full swing, but there is still time to plan a vacation — and even save some money, while you're at it.
'Meltdown': A week later, WestJet continues to feel the fallout from mechanics strike
One week after it ended, WestJet continues to feel the effects of a mechanics strike that nearly shut down the airline's network for 29 hours.
ANALYSIS Why are Trudeau and Singh avoiding Stampede this year?
This year, only Conservative leader Pierre Poilievre will be saddling up for the event, while both Prime Minister Justin Trudeau and NDP leader Jagmeet Singh will stay away.
As Biden continues campaigning, some House Democrat leaders say he should step aside
Some leading congressional Democrats privately suggested it was time for U.S. President Joe Biden to abandon his reelection bid.
Woman dies at Rolling Stones concert in Vancouver
A woman attending the Rolling Stones concert at BC Place died Friday night, police confirmed.